Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001662579-25-000053

Director acquired 7,616 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Anderson Kenneth Carl · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-07-01 Grant or award : show line 1 in the form +7,616 $1.51 $11,500 135,225 D
Loading xslF345X05/wk-form4_1751487429.xml…